Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia
#3PRI RANKED
Most Cited Paper
in Receptor Mechanisms and Signaling
18 Months Post-Publication
Class of 2026
“Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
xanomeline-trospium chloride · xanomeline-trospium chloride · M1/M4 muscarinic receptor agonist · Trospium chloride · peripheral muscarinic receptor antagonist · schizophrenia · acute psychosis · PANSS total score · PANSS positive subscale · PANSS negative subscale · PANSS Marder negative factor · Clinical Global Impression-Severity · non-D2 dopamine receptor mechanism · extrapyramidal symptoms · EMERGENT-3 trial · gastrointestinal adverse events · muscarinic receptor activation · Antipsychotic efficacy · weight gain · somnolence
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Receptor Mechanisms and Signaling Papers, Class of 2026. https://pri.pepkio.com/top-papers/receptor-mechanisms-and-signaling/2026. Accessed 2026-07-29. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459